Dongsheng Tu

Dongsheng Tu

UNVERIFIED PROFILE

Are you Dongsheng Tu?   Register this Author

Register author
Dongsheng Tu

Dongsheng Tu

Publications by authors named "Dongsheng Tu"

Are you Dongsheng Tu?   Register this Author

100Publications

3084Reads

25Profile Views

Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?

J Oncol Pract 2019 Sep 15;15(9):e807-e824. Epub 2019 Jul 15.

Canadian Cancer Trials Group, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00691DOI Listing
September 2019

Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study.

Br J Cancer 2019 Aug 6;121(5):425-428. Epub 2019 Aug 6.

Ovarian Cancer Program, Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0543-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738091PMC
August 2019

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial.

BMC Cancer 2019 Jun 7;19(1):552. Epub 2019 Jun 7.

Division of Health Policy and Management, Department of Public Health Sciences and Associate Director, Center for Healthcare Policy and Research, 2103 Stockton Blvd, Sacramento, CA, 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5779-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555934PMC
June 2019

Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218.

Pediatr Blood Cancer 2019 03 4;66(3):e27540. Epub 2018 Nov 4.

Department of Pediatrics, University of Toronto and New Agent and Innovative Therapy Program, The Hospital for Sick Children, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.27540
Publisher Site
http://dx.doi.org/10.1002/pbc.27540DOI Listing
March 2019

A single-index threshold Cox proportional hazard model for identifying a treatment-sensitive subset based on multiple biomarkers.

Stat Med 2018 10 4;37(23):3267-3279. Epub 2018 Jun 4.

Department of Public Health Sciences, Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/sim.7837
Publisher Site
http://dx.doi.org/10.1002/sim.7837DOI Listing
October 2018

Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial.

Br J Cancer 2018 07 14;119(1):12-18. Epub 2018 Jun 14.

Ovarian Cancer Program, Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0036-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035193PMC
July 2018

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.

J Clin Oncol 2018 02 12;36(6):563-571. Epub 2018 Jan 12.

Julie Lemieux, Centre Hospitalier Universitaire de Québec, Quebec City, Quebec; Michael D. Brundage, Cancer Centre of Southeastern Ontario at Kingston General Hospital; Wendy R. Parulekar, Kate Whelan, and Dongsheng Tu, Canadian Cancer Trials Group, Kingston; Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto; Timothy J. Whelan, McMaster University and Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada; Paul E. Goss, Massachusetts General Hospital Cancer Center, Boston, MA; James N. Ingle, North Central Cancer Treatment Group, Mayo Clinic, Rochester, NY; Paul Celano; Greater Baltimore Medical Center, Baltimore, MD; Hyman Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Julie Gralow, University of Washington, Seattle, WA; and Kathrin Strasser-Weippl, Wilhelminen Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.75.7500
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.75.7500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815404PMC
February 2018

A generalized partially linear mean-covariance regression model for longitudinal proportional data, with applications to the analysis of quality of life data from cancer clinical trials.

Stat Med 2017 05 19;36(12):1884-1894. Epub 2017 Feb 19.

Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.7240DOI Listing
May 2017

Jointly modeling longitudinal proportional data and survival times with an application to the quality of life data in a breast cancer trial.

Lifetime Data Anal 2017 04 24;23(2):183-206. Epub 2015 Sep 24.

Departments of Public Health Sciences and Mathematics and Statistics, Queen's University, Kingston, ON, K7L 3N6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10985-015-9346-8DOI Listing
April 2017

Factors Associated With Early Discontinuation of Study Treatment in the Mammary Prevention.3 Breast Cancer Chemoprevention Trial.

J Clin Oncol 2017 Feb 9;35(6):629-635. Epub 2017 Jan 9.

Olivia Meggetto, Dongsheng Tu, and Harriet Richardson, Queen's University; Dongsheng Tu and Harriet Richardson, Canadian Cancer Trials Group, Kingston, Ontario; Elizabeth Maunsell, Centre de Recherche du Centre Hospitalier Universitaire de Québec, Québec City, Québec, Canada; Rowan Chlebowski, Harbor-University of California, Los Angeles, Medical Center, Torrance, CA; Paul Goss, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.68.8895
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.68.8895DOI Listing
February 2017

Survival analysis following dynamic randomization.

Contemp Clin Trials Commun 2016 Aug 10;3:39-47. Epub 2016 Mar 10.

NCIC Clinical Trials Group, Queen's University, Kingston, ON K7E 3L6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.conctc.2016.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935860PMC
August 2016

Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.

Pain 2016 07;157(7):1532-40

Departments of aAnesthesiology and Perioperative Medicine and bBiomedical and Molecular Sciences, Queen's University, Kingston, Canada cUniversity of Toronto, Department of Anesthesia, University of Toronto, Toronto, Canada dPublic Health Sciences eMathematics and Statistics fPsychology and gPsychiatry, Queen's University, Kingston, Canada hDivision of Rheumatology, Department of Medicine Queen's University, Kingston, ON, Canada iDepartment of Anesthesiology and Perioperative Medicine, Queen's University, Kingston, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.pain.0000000000000558DOI Listing
July 2016

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

N Engl J Med 2016 Jul 5;375(3):209-19. Epub 2016 Jun 5.

From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1604700DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024713PMC
July 2016

Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.

Clin Cancer Res 2016 05;22(10):2435-44

Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia. School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0414DOI Listing
May 2016

Phase II study of PX-866 in recurrent glioblastoma.

Neuro Oncol 2015 Sep 20;17(9):1270-4. Epub 2015 Jan 20.

CancerCare Manitoba, Winnipeg, Canada (M.W.P., S.B.); Queen's University, Department of Oncology, Kingston, Canada (E.A.E.); Dalhousie University,Halifax, Canada (M.V.M.); BritishColumbia Cancer Agency, Vancouver, Canada (B.T.); Tom Baker Cancer Centre, Calgary, Canada (J.C.E.); London Regional Cancer Program, London, Canada (D.R.M.); University of Alberta, Edmonton, Canada (D.D.E.); Allan Blair Cancer Center, Regina, Canada (A.S.K., M.S., H.C.); Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada (J.S.); Department of Pathology, University Health Network, University of Toronto, Toronto, Canada (M.S.T., S.K.-R.); NCIC Clinical Trials Group, Queen's University, Kingston, Canada (D.T., J.P.); Oncothyreon, Inc., Seattle, Washington (D.F.H.); Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (W.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588751PMC
September 2015

Combination of morphine with nortriptyline for neuropathic pain.

Pain 2015 Aug;156(8):1440-8

Departments of aAnesthesiology & Perioperative Medicine and Biomedical & Molecular Sciences, bPublic Health Sciences and Mathematics & Statistics, and cPsychology, Queen's University, Kingston, ON, Canada dSection of Neurology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada eDepartment of Anesthesiology, Kingston General Hospital, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.pain.0000000000000149DOI Listing
August 2015

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Oncologist 2015 May 23;20(5):474-82. Epub 2015 Apr 23.

Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425383PMC
May 2015

The effect of triple vs. double nonopioid therapy on postoperative pain and functional outcome after abdominal hysterectomy: a randomised double-blind control trial.

Eur J Anaesthesiol 2015 Apr;32(4):269-76

From the Department of Anesthesiology & Perioperative Medicine (IG, DD-S, SD, RR, EO), Department of Biomedical & Molecular Sciences (IG), Centre for Neuroscience Studies (IG), Department of Mathematics & Statistics (DT), and Department of Obstetrics & Gynaecology, Queen's University, Kingston, Ontario, Canada (MM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EJA.0000000000000190DOI Listing
April 2015

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.

J Clin Oncol 2014 May 7;32(14):1427-36. Epub 2014 Apr 7.

Elizabeth Maunsell, Centre de recherche du Centre hospitalier universitaire (CHU) de Québec, (Axe Oncologie), Québec; Pierre Dubé, Hôpital Maisonneuve-Rosemont, Montreal, QC; Andrew L. Cooke, CancerCare Manitoba, Winnipeg, MB; Silvana Spadafora, Algoma District Cancer Program, Sault Ste. Marie, ON; Lavina Lickley, Women's College Hospital; Angela M. Cheung, University Health Network, University of Toronto, Toronto; Dianne Johnston, Andrea Hiltz, Michael Brundage, Dongsheng Tu, and Harriet Richardson, National Cancer Institute of Canada Clinical Trials Group; Joseph Pater, Queens University, Kingston, ON; Susan L. Ellard, British Columbia Cancer Agency-Southern Interior, Kelowna; Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, BC, Canada; Paul E. Goss, Massachusetts General Hospital, Boston, MA; Rowan T. Chlebowski, University of California at Los Angeles Medical Centre, Torrance, CA; James N. Ingle and Sandhya Pruthi, Mayo Clinic, Rochester, MN; José E. Alés Martínez, Hospital N. S. Sonsoles, Ávila; Amparao Ruiz, Instituto Valenciano de Oncologia, Valencia, Spain; Gloria E. Sarto, Center for Women's Health & Health Research, University of Wisconsin, Madison, WI; Carol J. Fabian, University of Kansas Medical Center, Kansas City, KS; Pascal Pujol, CHU-Hôpital Arnaud de Villeneuve, Montpellier, France; Susan Hendrix, Hutzel Women's Health Specialists, Detroit, MI; Debra W. Thayer, MedStar Health Research Institute, Hyattsville, MD; Kendrith M. Rowland, Carle Cancer Centre/Mills Breast Cancer Institute, Urbana, IL; and Jean Wactawski-Wende, State University of New York at Buffalo, Buffalo, NY.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/04/03/JCO.2013.51
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.51.2483
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.2483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879707PMC
May 2014

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Clin Cancer Res 2014 Feb 11;20(3):744-53. Epub 2013 Nov 11.

Authors' Affiliation: Flinders University, Flinders Centre for Innovation in Cancer; Department of Medical Oncology, Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0606DOI Listing
February 2014

Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer.

Gynecol Oncol 2013 Nov 9;131(2):315-20. Epub 2013 Aug 9.

Ottawa Hospital Research Institute, University of Ottawa, 501 Smyth Road, Ottawa, Ontario K1H 5L3, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.08.004DOI Listing
November 2013

Weighted rank tests for noninferiority hypotheses based on paired survival times.

J Biopharm Stat 2013 Mar;23(2):432-46

Department of Biostatistics and Social Medicine, School of Public Health, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10543406.2011.616971DOI Listing
March 2013

Sensory and affective pain descriptors respond differentially to pharmacological interventions in neuropathic conditions.

Clin J Pain 2013 Feb;29(2):124-31

Department of Anesthesiology & Perioperative Medicine, Queen's University, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AJP.0b013e31824ce65cDOI Listing
February 2013

Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.

Breast Cancer Res Treat 2012 Dec 23;136(3):769-76. Epub 2012 Oct 23.

Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2294-z
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2294-zDOI Listing
December 2012

Variable selection in semiparametric cure models based on penalized likelihood, with application to breast cancer clinical trials.

Stat Med 2012 Oct 26;31(24):2882-91. Epub 2012 Jun 26.

Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.5378DOI Listing
October 2012

Nonparametric confidence intervals for the ratio of marginal hazard rates of paired survival times.

Biom J 2012 Mar 13;54(2):197-213. Epub 2012 Mar 13.

Department of Biostatistics and Social Medicine, School of Public Health, Fudan University, Shanghai, P. R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bimj.201100048DOI Listing
March 2012

Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial.

Breast Cancer Res Treat 2012 Jan 1;131(2):541-51. Epub 2011 Nov 1.

Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1840-4DOI Listing
January 2012

A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials.

BMC Med Res Methodol 2011 Jun 21;11:95. Epub 2011 Jun 21.

McMaster University, Juravinski Cancer Centre, 699 Concession St,, Hamilton, Ontario, L8V 5C2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2288-11-95DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138426PMC
June 2011

Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.

Eur J Cancer 2011 Apr 4;47(6):854-63. Epub 2011 Feb 4.

NCIC Clinical Trials Group and Queen's University Cancer Research Institute, Kingston, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.12.005DOI Listing
April 2011

Phase II cancer clinical trials with a one-sample log-rank test and its corrections based on the Edgeworth expansion.

Contemp Clin Trials 2011 Jan 1;32(1):108-13. Epub 2010 Oct 1.

Department of Mathematics and Statistics, Queen's University, Kingston, Ontario, Canada K7L 3N6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2010.09.009DOI Listing
January 2011

A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group.

Cancer 2010 Jan;116(2):362-8

Department of Medical Oncology, Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Ottawa ON K1H 8L6, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.24745
Publisher Site
http://dx.doi.org/10.1002/cncr.24745DOI Listing
January 2010

Confidence intervals for the first crossing point of two hazard functions.

Lifetime Data Anal 2009 Dec 1;15(4):441-54. Epub 2009 Nov 1.

Department of Statistical Science, University College London, Gower Street, London WC1E 6BT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10985-009-9132-6DOI Listing
December 2009

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.

Lancet 2009 Oct 30;374(9697):1252-61. Epub 2009 Sep 30.

Department of Anesthesiology, Queen's University, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(09)61081-3DOI Listing
October 2009

Alternate endpoints for screening phase II studies.

Clin Cancer Res 2009 Mar 10;15(6):1873-82. Epub 2009 Mar 10.

Princess Margaret Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2034DOI Listing
March 2009

Phase II stopping rules that employ response rates and early progression.

J Clin Oncol 2008 Aug;26(22):3715-20

Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.1044DOI Listing
August 2008

NCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting.

Expert Rev Pharmacoecon Outcomes Res 2008 Jun;8(3):243-53

Division of Cancer Control and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, K7L 3N6, Canada.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737167.8.3.243
Publisher Site
http://dx.doi.org/10.1586/14737167.8.3.243DOI Listing
June 2008

Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example.

Breast Cancer Res Treat 2008 Mar 3;108(2):265-9. Epub 2007 May 3.

Cancer Research Institute, Queen's University, 10 Stuart St., Kingston, ON, Canada K7L 3N6.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-007-9595-7
Publisher Site
http://dx.doi.org/10.1007/s10549-007-9595-7DOI Listing
March 2008

Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.

J Clin Oncol 2007 Nov;25(32):5078-81

Department of Oncology, and National Cancer Institute of Canada Clinical Trials Group Queen's Cancer Research Institute, Queens University, Kingston, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.4645DOI Listing
November 2007

Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.

Authors:
Dongsheng Tu

Biom J 2007 Jun;49(3):474-83

National Cancer Institute of Canada Clinical Trials Group, Queen's University, 10 Stuart Street, Kingston, Ontario, Canada K7L 3N6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bimj.200610323DOI Listing
June 2007

Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.

Breast Cancer Res Treat 2006 Dec 6;100(3):263-71. Epub 2006 Jul 6.

National Cancer Institute of Canada Clinical Trials Group, Cancer Research Institute, Queens University, 10 Stuart Street, K7L3N6, Kingston, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-006-9257-1DOI Listing
December 2006